An Intro To Cannabinoids | CBN, CBC, CBDV, CBG, CBD | Sanobiotec

Beyond THC and CBD – A Guide to Nature’s Chemical Diversity

From THC and CBD to over 100 other compounds found in cannabis plants, cannabinoids represent one of nature’s most diverse chemical families. As the leading manufacturer of minor cannabinoids across the United States, Europe, and Japan, Sanobiotec explores the potential of lesser-known compounds like CBN, THCV, and CBC.

While major cannabinoids THC and CBD make up about 90% of the cannabis plant’s cannabinoid content, emerging research suggests that minor cannabinoids—though present in much smaller quantities—may offer their own unique benefits worth investigating.

What Are Cannabinoids?

Cannabinoids are a diverse family of compounds predominantly found in the cannabis plant. Depending on their abundance in the plant, cannabinoids can be categorized as either major or minor cannabinoids. Based on their origins, cannabinoids are classified into three groups: phytocannabinoids, endocannabinoids, and synthetic cannabinoids.

Minor vs. Major Cannabinoids

Most people are familiar with major cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD). These compounds dominate the cannabis industry and are the most researched. At Sanobiotec, we explore the potential of lesser-known minor cannabinoids, which may offer unique applications, making them highly versatile and adaptable for various uses. It’s time to look beyond THC and CBD to discover the broader range of cannabinoid possibilities.

Why Are Cannabinoids Important?

We believe in exploring the full range of cannabinoids, and how they can be applied across various industries. Ongoing studies are investigating their potential roles in areas like pain management, inflammation, and other applications.

At Sanobiotec, we understand that companies need reliable research and development partners to explore the latest advancements in cannabinoids. Our focus extends from the synthesis of cannabinoid molecules to their final applications in various products. We’re committed to advancing the field and providing high-quality cannabinoids for industries such as wellness and cosmetics.

A list of minor cannabinoids and the current research:

Cannabinol (CBN)

Cannabinol (CBN) is currently being researched for its potential to promote relaxation. A double-blind, randomized, placebo-controlled study suggested that 20 mg of CBN taken nightly may help improve sleep disturbance and reduce awakenings compared to a placebo, although the effect on sleep quality was not statistically significant[1][2]. Additional studies are investigating CBN’s role in sleep improvement in individuals with insomnia[5].

Cannabigerol (CBG)

Cannabigerol (CBG) is being studied for its potential anti-inflammatory properties. Research indicates that CBG may influence immune responses in conditions like inflammatory bowel disease[3]. Other studies are examining CBG’s potential neuroprotective effects[6].

Cannabichromene (CBC)

Cannabichromene (CBC) is under investigation for its possible role in mood regulation and inflammation. Research suggests that CBC may interact with the endocannabinoid system, enhancing the effects of other cannabinoids and potentially contributing to mood improvement and pain relief[3][4].

Tetrahydrocannabivarin (THCV)

THCV is being studied for its potential in appetite regulation. Preliminary findings indicate that THCV may influence appetite and promote energy, and it’s being explored in research related to obesity and metabolic health[3]. Studies in animal models are also examining its potential effects on cognitive function[6].

Cannabidivarin (CBDV)

CBDV is being researched for its potential role in managing neurological conditions and seizures. Studies suggest that CBDV may have anticonvulsant properties, especially in specific types of epilepsy, and further research is underway to understand its broader implications[3][4].

Delta-8-Tetrahydrocannabinol (Δ8-THC)

Delta-8-Tetrahydrocannabinol (Δ8-THC) is being explored for its potential therapeutic benefits, offering a milder psychoactive effect than Δ9-THC. Research suggests it may have potential in anxiety relief and appetite regulation[3][4].

Cannabidiolic Acid (CBDA)

CBDA is under investigation for its potential anti-inflammatory properties. Research shows that CBDA may inhibit the COX-2 enzyme, which is involved in inflammation pathways[3][6].

Cannabigerolic Acid (CBGA)

CBGA is being studied for its potential to alleviate inflammation and pain. As a precursor to other cannabinoids, CBGA’s effects are of significant interest to researchers exploring its therapeutic potential[3][4].

Cannabicyclol (CBL)

Initial research on Cannabicyclol (CBL) suggests potential pharmacological properties, although more studies are required to determine its full range of effects[3][6].

Cannabielsoin (CBE)

Cannabielsoin (CBE) is a cannabinoid under early-stage research, with preliminary findings indicating potential applications. More comprehensive studies are needed to evaluate its safety and efficacy[3][4].

Cannabitriol (CBT)

Cannabitriol (CBT) is another cannabinoid currently under investigation. Although limited studies exist, research is ongoing to explore its potential pharmacological actions[3][6].

Cannabivarin (CBV)

Research on Cannabivarin (CBV) is still in its early stages. Preliminary findings indicate potential applications, but more studies are necessary to confirm these effects[3][4].

Tetrahydrocannabinolic Acid (THCA)

THCA is being investigated for its potential non-psychoactive benefits. Prior research suggests that THCA may have anti-inflammatory properties, although further studies are required to confirm these effects[3][4].

Cannabichromenic Acid (CBCA)

CBCA, a precursor to CBC, is being researched for its potential anti-inflammatory effects. Current studies are investigating its role in inflammation and pain management[3][4].

Cannabidivarinic Acid (CBDVA)

CBDVA is a precursor to CBDV, and research is exploring its role in neurological conditions. Preliminary findings indicate that it may share some of the properties of CBDV, but more research is necessary to understand its full potential[3][4].

Tetrahydrocannabivarinic Acid (THCVA)

THCVA is being studied as a precursor to THCV. Early findings suggest that it may exhibit appetite-regulating properties similar to THCV, but further research is needed[3][4].

Cannabidiphorol (CBDP)

Cannabidiphorol (CBDP) is a newly discovered cannabinoid, with ongoing research exploring its unique properties. Early studies suggest that CBDP may have distinct pharmacological actions, making it a subject of interest for further exploration[3][6].

Tetrahydrocannabiphorol (THCP)

Tetrahydrocannabiphorol (THCP) has been recently identified and is under investigation for its potential therapeutic effects. Initial studies suggest it may be significantly more potent than THC, indicating promising applications for future research[3][6].

Citations:[1] https://pubmed.ncbi.nlm.nih.gov/37796540/[2] https://bmjopen.bmj.com/content/13/8/e071148[3] https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00153-w[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC10490534/[5] https://www.sleepfoundation.org/sleep-aids/cbn-for-sleep[6] https://www.explorationpub.com/journals/em/article/1001171[7] https://www.sciencedirect.com/science/article/pii/S0926669024003364[8] https://www.researchgate.net/publication/315850553_Cannabis_Cannabinoids_and_Sleep_a_Review_of_the_Literature

This summary provides information on research related to cannabinoids. These statements have not been evaluated by regulatory bodies, such as the Food and Drug Administration. This article is not intended to diagnose, treat, cure, or prevent any disease. Sanobiotec provides this summary solely to inform the reader of the research being conducted on cannabinoids.